L'UGM & Conference est un événement de 4 jours axé sur les applications de la chimie computationnelle, la conception et la découverte de médicaments dans les domaines des agents biologiques et des petites molécules, comprenant des ateliers, des présentations scientifiques, des affiches, ainsi que des opportunités de socialiser lors de réceptions et de dîner de conférence. Toute personne intéressée est la bienvenue. Les places sont limitées, une inscription anticipée est donc recommandée.
Chemical Computing Group organise les ateliers suivants sur la conception de médicaments assistée par ordinateur. La participation aux ateliers est gratuite mais une pré-inscription est requise. Une inscription anticipée est recommandée car les places sont limitées. Des ordinateurs seront fournis. Aucune expérience préalable du logiciel MOE n’est requise.
In our next episode, we’re joined by Jason Cole, a Senior Research Fellow at the Cambridge Crystallographic Data Center (CCDC). He shares his fascinating journey, starting from his childhood in Italy, where his love for science blossomed, all the way to his impressive career in computational chemistry and crystallography. We chat about what CCDC does in terms of gathering and sharing crystallographic data, the ups and downs of software development in this field, and why it’s so crucial to validate docking software. Jason also highlights the importance of data standards, the philanthropic mission of CCDC, and what the future holds for drug discovery, particularly with the exciting possibilities of artificial intelligence (AI) and quantum computing. It’s a great conversation packed with insights!
Description: In our first episode of 2025, our hosts, Chris Williams and Dave Thompson, have the pleasure of speaking to Fernando Garces, CEO and co-founder of BioGlyph. Leading us from the sunny climes of Portugal through the tropical paradise that is London, on route to the West Coast of the US and A, Fernando shares his evolving love of science through the heights of academia, into industry, and now as CEO of a software company he co-founded to improve the modeling of complex multispecifics. Important questions are unpacked throughout - is London really a tropical paradise? How long can we keep milking podcast episode titles that take advantage of the homophonic property of pharma and farm? Oh, and we have another surprising guest answer to the ‘Deschênes Dilemma’… It is not to quote G. K. Chesterton, a proper nailbiter!